Plain-English translation of NCT06738849 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a smartphone application called EkiYou V2 that helps people with diabetes calculate the right amount of insulin to take with meals. The app uses information about what you eat, your blood sugar levels, and your physical activity to give you personalized insulin dose recommendations. This is a new version of a device that has already been approved in Europe.
Many people with diabetes struggle to calculate the right insulin doses on their own, which can lead to blood sugar levels that are too high or too low. This treatment is being studied to see whether it can help people manage their insulin more accurately and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic 3 times over 6 months. When you join, you'll be randomly assigned to either start using the app right away or continue your normal insulin management for 3 months first, then switch to using the app. Throughout the study, you'll answer brief questions on your phone about how satisfied you are with managing your diabetes and how it affects your daily life. The app connects to your existing glucose monitor and helps you calculate insulin doses based on your meals, activity, and blood sugar readings.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France